Topic: pharma CEO

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.

Flemming Ornskov, Shire’s most recent CEO and who orchestrated the Baxalta takeover and later the selloff to Takeda, is now Galderma's CEO.

GSK CEO Emma Walmsley has joined over 100 prominent U.K. businesswomen in a campaign aimed at closing the gender pay gap.

Sanofi CEO Paul Hudson hinted at a coming shakeup—from diabetes to cancer and R&D to marketing. And he's planning to unveil those plans December 10.

Big Pharma CEOs have their own way of cozying up to the world’s second largest pharmaceutical market—by getting themselves Chinese names.

Low interest rates and strong stock valuations are two top reasons why U.S. drugmakers are on the move for deals.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.

The way CEO Kåre Schultz figures it, Teva Pharmaceutical can make more manufacturing cuts after reaching its $3 billion cost reduction goal.

We're making a list of the top broken promises by pharma execs in recent years, and we need your help with nominations.

Merck is scouting replacements for CEO Ken Frazier with a preference toward an internal candidate, Bloomberg reports.